血管内皮抑素研究进展
摘要
1971年Folkman提出了一个里程碑式的假说——血管生成假说,即实体肿瘤的生长和转移依赖新生血管的形成。阻断血管生成能够有效抑制肿瘤生长。这一假说后被多方验证并得到公认,使抗血管生成成为肿瘤治疗领域的一条新的途径和手段。血管内皮抑素(ES)的发现与血管抑素的发现基于同一个现象——“原位肿瘤可以抑制转移灶形成”现象,
出处
《浙江医学》
CAS
2011年第9期1409-1412,共4页
Zhejiang Medical Journal
参考文献30
-
1O'Reilly M S,Boehm T,Shing Y,et al.Endostatin:all endogenous inhibitor of angiogenesis and tumor growth[J].Cell,1997,88(2):277-285.
-
2Wang J,Sun Y,Liu Y,et al.Results of phase Ⅲ trial of rh-endostatin (YH-16) in advanced non-small cell lung cancer (NSCLC)patients[J].Chinese Journal of Lung Cancer,2005,8(4):283-290.
-
3Oh S P,Kamagata Y,Muragaki Y,et al.Isolation and sequeneing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collageneous proteins[J].Proc Natl Acad Sci USA,1994,91(10):4229-4233.
-
4Yamaguchi N,Anand-Apte B,Lee M,et al.Endostatin inhibits VEGF-induced endothelial cell migration an tumor growth independently of zinc binding[J].EMBO J,1999,18(16):4414-4423.
-
5Iughetti P,Suzuki O,Godoi P,et al.A polymorphism in endostatin,an angiogenesis inhibitor,predisposes for the development of prostatic adenocarcinoma[J].Cancer Res,2001,61(20):7375-7378.
-
6Yang Q,Rasmussen S A,Friedman J M,et al.Mortality associated with Down's syndrome in the USA from 1983 to 1997:a populationbased study[J].Lancet,2002,359(9311):1019-1025.
-
7Sund M,Hamano Y,Sugimoto H,et al.Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors[J].Proc Natl Acad Sci USA,2005,102(8):2934-2939.
-
8Tsuboi S,Nouso K,Tomono Y,et al.Anti-endostatin monoclonal antibody enhances growth of human hepatocellular carcinoma cells by inhibiting activity of endostatin secreted by the transplanted cells in nude mice[J].Int J Oncol,2004,25(5):1267-1271.
-
9Karumanchi S A,Jha V,Ramchandran R,et al.Cell surface glypicans are low-affinity endostatin receptors[J].Mol Cell,2001,7(4):811-822.
-
10Wickstr S A,Alitalo K,Keski-Oja J,.Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity[J].J Biol Chem,2003,278(39):37895-37901.
二级参考文献9
-
1张兆伟 张金芝 等.小鼠肺腺癌(LA-795)细胞株的建立及一些生物学特性的研究[J].中华肿瘤杂志,1985,7(2):83-83.
-
2O'Reilly MS,Boehm T,Shing Y,et al.Endostatin: an endogenous inhibitor of angiogenesis and tumor growth [J].Cell,1997,88 (2): 277-285.
-
3O'Reilly MS,Holmgren L,Shing Y,et al.Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma [J].Cell,1994,79(2): 315-328.
-
4Saphir A.Angiogenesis: The unifying concept in cancer [J].J Natl Cancer Inst,1997,89(22): 1658-1662.
-
5Weidner N.Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors [J].Breast Cancer Res Treat,1995,36(2): 169-180.
-
6Wijsmal JH,Jonker RR,Keijzer,et al.A new method to detect apoptosis in paraffin sections in situ end-labeling of fragmented DNA [J].J Histochem Cytochem,1993,41(1): 7-12.
-
7Boehm T,Folkmam J,Browder T,et al.Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].Nature,1997,390(6658): 404-407.
-
8Thompson CB.Apoptosis in the pathogenesis and treament of disease [J].Science,1995,267(5): 1456-1462.
-
9Drixler TA,Borel-Rinkes IHM,Ritchies ED,et al.Continous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy [J].Cancer Res,2000,60(6): 1761-1765.
共引文献25
-
1杨芳,何援利,姜孝玉,刘芸,彭冬先,宗利丽.人内皮抑素基因的克隆、表达、纯化及活性测定[J].第一军医大学学报,2005,25(4):416-418. 被引量:5
-
2魏增涛,卢爱英,王晓燕,马春红,孙汶生,张艳,朱法良,郭春.内皮抑素基因联合重组干扰素-α蛋白对卵巢癌抑制作用的研究[J].实用妇产科杂志,2005,21(10):594-594. 被引量:3
-
3刘玉,丁彦青,辛晓燕,韩良辅,梁莉.乙酰肝素酶的外源性表达对大肠癌HT29细胞侵袭性的影响[J].癌症,2005,24(12):1427-1430. 被引量:5
-
4刘玉,丁彦青,辛晓燕,刘淑娟,王德堂,郭惠玲.乙酰肝素酶基因表达增强大肠癌转化细胞侵袭能力的实验研究[J].肿瘤防治研究,2006,33(4):242-245. 被引量:1
-
5张明川,梅同华.抗肺癌血管生成治疗的进展[J].国际呼吸杂志,2006,26(6):467-470. 被引量:4
-
6楚朝辉,曾庆黎.SU6668和Endostatin治疗大肠癌的研究进展[J].江西医药,2007,42(8):760-762. 被引量:1
-
7李虎,李小静,宁金龙,孟刚,高凤山,董继英.血管生长抑制因子对兔耳增生性瘢痕的作用及意义[J].中华医学美学美容杂志,2007,13(4):237-239. 被引量:8
-
8栾桂红,李铭新,郑秋月.体外重组内皮抑素及其抑制肿瘤血管生成机制探讨[J].国际检验医学杂志,2007,28(9):775-776. 被引量:2
-
9周琪,梁后杰,阎晓初,边志衡,周进明,彭秋平,吴峰,潘凤.人结肠癌裸鼠原位移植瘤模型的建立[J].重庆医学,2007,36(19):1929-1931. 被引量:10
-
10秦叔逵,刘秀峰,王琳,陈映霞,钱军,华海清,龚新雷,杨柳青,何泽明.重组人血管内皮抑素与化疗联合治疗肺外晚期恶性肿瘤的临床研究[J].临床肿瘤学杂志,2007,12(10):728-735. 被引量:89
-
1钟晓刚,殷舞,黄顺荣,秦千子,麦威,刘斐,黄蕤,黎丹戎.分泌型血管内皮抑素重组腺病毒的构建及其在基因治疗载体肝干细胞中的表达[J].中华肝脏病杂志,2009,17(8):628-629. 被引量:2
-
2庄洪卿,秦培艳,袁智勇.血管内皮抑素联合放射的机制研究进展[J].中华放射肿瘤学杂志,2010,19(3):280-282. 被引量:1
-
3阳苑,李宝兰,岳文涛.血管内皮抑素的蛋白修饰及其联合用药的临床前研究进展[J].结核病与胸部肿瘤,2012(3):222-226.
-
4唐羿,於建鹏.外周血血管内皮抑素和血管抑素检测在胰腺癌患者病程判断中的意义[J].临床外科杂志,2015,23(7):526-529.
-
5张冉冉,李里,夏荣耀(综述),姜秋颖(审校).血管内皮抑素与肿瘤关系研究进展[J].肿瘤研究与临床,2013,25(3):211-213. 被引量:1
-
6马勤.肿瘤基质干细胞促进原位肿瘤生长机制首获揭示[J].首都医药,2013(1):11-11.
-
7李淑芬,佟仲生.血管内皮抑素在非小细胞肺癌治疗中的研究进展[J].中国肿瘤临床,2008,35(18):1076-1079. 被引量:1
-
8张一鸣,王若宁,李艳利,顾冬民,程志祥,熊俊,德伟,陈丙莺.血管内皮抑素的原核表达及多克隆抗体的制备[J].癌症,2002,21(9):957-960. 被引量:1
-
9张志明,于静萍,孙苏平.血管内皮抑素抗肿瘤研究进展[J].国际肿瘤学杂志,2011,38(5):345-348. 被引量:2
-
10马鲲鹏,马丽敏.血管内皮抑素在喉癌声门上型中的表达[J].中国耳鼻咽喉头颈外科,2012,19(10):552-554.